Delayed targeted atelectasis in a case of bronchoscopic lung volume reduction with endobronchial valves.

Autor:	Chandra NC; Division of Pulmonary, Allergy and Sleep Medicine, Mayo Clinic in Florida, Jacksonville, Florida, USA chandra.nikitha@mayo.edu., Fernandez-Bussy I; Pontificia Universidad Católica Argentina, Buenos Aires, Buenos Aires, Argentina., Walsh KL; Division of Pulmonary, Allergy and Sleep Medicine, Mayo Clinic in Florida, Jacksonville, Florida, USA., Abia-Trujillo D; Division of Pulmonary, Allergy and Sleep Medicine, Mayo Clinic in Florida, Jacksonville, Florida, USA.
Jazyk:	angličtina
Zdroj:	BMJ case reports [BMJ Case Rep] 2024 Apr 25; Vol. 17 (4). Date of Electronic Publication: 2024 Apr 25.
DOI:	10.1136/bcr-2023-256573
Abstrakt:	A woman in her late 60s with severe chronic obstructive pulmonary disease (COPD) and emphysema underwent bronchoscopic lung volume reduction (BLVR) with endobronchial valves (EBV) to address hyperinflation. The initial EBV placement has led to partial lobar atelectasis of the left lower lobe and resulted in significant improvement in the patient's symptoms and lung function. However, valve migration occurred later due to pneumothorax unrelated to valves, leading to suboptimal clinical improvement. The patient achieved delayed full lobar atelectasis 21 months after EBV placement, which led to a significant clinical improvement. The patient decided to be delisted from the lung transplant list due to the improvement. This case highlights the importance of considering delayed atelectasis as a possible outcome of EBV placement and suggests the need for further exploration of the long-term implications and associations of this procedure. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu